We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+18.18%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$4.65B
AUM Growth
+$265M
(+6%)
Cap. Flow
+$90.1M
Cap. Flow
% of AUM
1.94%
Top 10 Holdings %
Top 10 Hldgs %
14.76%
Holding
1,541
New
606
Increased
154
Reduced
157
Closed
549
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$22.7M |
| 2 |
Biogen
BIIB
|
+$20.4M |
| 3 |
Newmont
NEM
|
+$17.6M |
| 4 |
Centene
CNC
|
+$14.6M |
| 5 |
Wayfair
W
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$25.5M |
| 2 |
SolarEdge
SEDG
|
+$22.3M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$19.6M |
| 4 |
Teck Resources
TECK
|
+$19.4M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.25% |
| 2 | Consumer Discretionary | 3.98% |
| 3 | Technology | 1.67% |
| 4 | Materials | 1.07% |
| 5 | Industrials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
751
Teck Resources
TECK
$29.6B
| $692K | 0.01% |
36,100
-958,100
| -96% | -$19.4M |
|
|
ESPR
752
DELISTED
Esperion Therapeutics
ESPR
| $691K | 0.01% |
+24,650
| New | +$727K |
|
753
STMicroelectronics
STM
$46.7B
| $690K | 0.01% |
+18,000
| New | +$702K |
|
|
ZGNX
754
DELISTED
Zogenix, Inc.
ZGNX
| $684K | 0.01% |
+35,000
| New | +$718K |
|
755
SLB Ltd
SLB
$73.6B
| $680K | 0.01% |
+25,000
| New | +$658K |
|
756
NIO
NIO
$12.2B
| $678K | 0.01% |
+17,400
| New | +$887K |
|
|
HTT
757
PUT
High Templar Tech Ltd
HTT
$379M
| $678K | 0.01% |
297,700
-385,500
| -56% | -$921K |
|
758
PUT
Lumen
LUMN
$6.57B
| $667K | 0.01% |
50,000
-50,000
| -50% | -$621K |
|
759
Century Communities
CCS
$1.91B
| $663K | 0.01% |
+11,000
| New | +$598K |
|
|
TBIO
760
PUT
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $659K | 0.01% |
+40,000
| New | +$911K |
|
761
CALL
PBF Energy
PBF
$8.57B
| $658K | 0.01% |
+46,500
| New | +$555K |
|
|
KLRS
762
Kalaris Therapeutics
KLRS
$83.5M
| $656K | 0.01% |
+1,217
| New | +$1.02M |
|
763
PUT
Stratasys
SSYS
$679M
| $648K | 0.01% |
+25,000
| New | +$862K |
|
764
Neurocrine Biosciences
NBIX
$16.8B
| $643K | 0.01% |
6,609
-9,391
| -59% | -$985K |
|
|
STMP
765
DELISTED
Stamps.com, Inc.
STMP
| $638K | 0.01% |
+3,192
| New | +$680K |
|
766
PUT
SiriusXM
SIRI
$9.98B
| $636K | 0.01% |
+10,450
| New | +$637K |
|
767
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $635K | 0.01% |
+34,340
| New | +$702K |
|
768
AMC Global Media
AMCX
$492M
| $627K | 0.01% |
+11,800
| New | +$645K |
|
769
PUT
Calix
CALX
$2.26B
| $624K | 0.01% |
+18,000
| New | +$667K |
|
770
CALL
Theravance Biopharma
TBPH
$874M
| $611K | 0.01% |
+30,000
| New | +$570K |
|
|
771
PUT
Theravance Biopharma
TBPH
$874M
| $611K | 0.01% |
+30,000
| New | +$570K |
|
772
Uranium Energy
UEC
$4.75B
| $606K | 0.01% |
+211,800
| New | +$462K |
|
773
PUT
Sibanye-Stillwater
SBSW
$6.26B
| $604K | 0.01% |
+33,800
| New | +$594K |
|
774
Nutanix
NTNX
$16B
| $601K | 0.01% |
+22,641
| New | +$689K |
|
775
Heron Therapeutics
HRTX
$93.9M
| $600K | 0.01% |
+37,000
| New | +$660K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q1 2021 Portfolio in Review
As of Q1 2021, Caption Management held 1,541 positions worth $4.65B, up 6% from $4.39B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Caption Management's Q1 2021 filing shows 606 new, 154 increased, 157 reduced and 549 closed positions. Its largest new stake was Amgen: 95,000 shares worth $23.6M. The largest sale was Enphase Energy, an estimated $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 3.2% a quarter earlier, followed by Consumer Discretionary and Technology.
- Caption Management's largest Q1 2021 buy was Amgen: 95,000 shares worth $23.6M.
- Caption Management added most to Wayfair in Q1 2021, an estimated $14.5M increase.
- Caption Management's biggest Q1 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $19.6M.
- Caption Management fully exited Enphase Energy in Q1 2021, selling an estimated $25.5M.
- Caption Management's ten largest holdings make up 15% of its $4.65B portfolio in Q1 2021.
- Caption Management opened 606 new positions and closed 549 in Q1 2021.
- Caption Management's portfolio value rose 6% quarter-over-quarter to $4.65B.
Based on Caption Management's 13F filing for Q1 2021, filed 17 May 2021.